Basic Information
ID: ALA4832676
Type: Binding
Description: Inhibition of human liver CatL assessed as fluorescence using Cbz-Phe-Arg-AMC as substrate measured at second inhibition step by fluorometric enzyme assays
Format: BAO_0000221
Organism: Homo sapiens
Tissue: Liver
Target: Cathepsin L(ALA3837)
Document: ALA4831511
Inhibition of human liver CatL assessed as fluorescence using Cbz-Phe-Arg-AMC as substrate measured at second inhibition step by fluorometric enzyme assays: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4832676
Ki
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 599.73 | 5.27 | 5.27 |
| 585.70 | 4.97 | 4.97 |
| 585.70 | 5.13 | 5.13 |
| 587.67 | 4.76 | 4.76 |
| 616.71 | 5.86 | 5.86 |
| 642.75 | 5.51 | 5.51 |
| 644.72 | 5.14 | 5.14 |
| 587.67 | 4.76 | 4.76 |
| 620.69 | 6.02 | 6.02 |
| 620.69 | 5.85 | 5.85 |
| 608.74 | 3.89 | 3.89 |
| 658.75 | 5.44 | 5.44 |
| 601.70 | 5.07 | 5.07 |
| 636.69 | 5.95 | 5.95 |
| 601.70 | 5.07 | 5.07 |
| 599.73 | 5.27 | 5.27 |
| 634.72 | 6.16 | 6.16 |
| 606.67 | 5.71 | 5.71 |
| 620.69 | 6.02 | 6.02 |
| 656.78 | 5.65 | 5.65 |
| 642.75 | 5.34 | 5.34 |
| 541.67 | 3.95 | 3.95 |
| 658.75 | 5.44 | 5.44 |
| 636.69 | 5.95 | 5.95 |
| 656.78 | 5.65 | 5.65 |
| 634.72 | 6.16 | 6.16 |